Skip to main content
. 2010 Aug 20;38(3):426–432. doi: 10.1093/schbul/sbq086

Table 1.

Demographics of Male Patients With Schizophrenia

Patient KYNA (nM) KYN (nM) TRP (μM) BPRS GAF Age (y) Olanzapine dose (mg) Smoking
SZ 1 1.57 52.27 1.96 29 63 27 2.5 N
SZ 2 3.27 37.55 1.48 25 68 41 7.5 N
SZ 3 2.29 66.51 1.68 33 62 49 25 Y
SZ 4 2.12 96.31 1.79 29 68 34 10 N
SZ 5 1.87 41.23 1.55 32 53 23 10 N
SZ 6 1.75 54.81 1.62 33 58 34 10 N
SZ 7 4.08 68.81 1.67 33 49 48 20 N
SZ 8 1.53 43.41 1.65 36 48 30 10 Y
SZ 9 2.87 60.17 1.87 46 52 38 12.5 N
SZ 10 1.89 74.22 1.74 46 45 43 20 N
SZ 11 0.67 49.38 2.33 36 65 42 15 N
SZ 12 0.98 51.91 1.72 35 48 33 10 Y
SZ 13 1.86 99.27 1.59 27 65 29 2.5 N
SZ 14 1.42 58.82 1.61 30 58 46 10 N
SZ 15 3.19 57.88 1.74 38 49 31 20 Y
SZ 16 1.19 58.36 1.69 31 61 38 7.5 N

Note: BPRS, Brief Psychiatric Rating scale; GAF, global assessment of functioning; KYN, kynurenine; KYNA, kynurenic acid; N, no; TRP, tryptophan; Y, yes.